Serum vitamin D status and bacterial vaginosis prevalence and incidence in Zimbabwean women

American Journal of Obstetrics and Gynecology

Volumn 215, Issue 3, 2016, Pages 332.e1-332.e10

  Turner, Abigail N ^a   Carr Reese, Patricia ^b   Chen, Pai Lien ^c   Kwok, Cynthia ^c   Jackson, Rebecca D ^a   Klebanoff, Mark A ^a   Fichorova, Raina N ^d   Chipato, Tsungai ^e   Morrison, Charles S ^c  

^a OHIO STATE UNIVERSITY   (United States)

^b GEORGE WASHINGTON UNIVERSITY SCHOOL OF MEDICINE AND HEALTH SCIENCES   (United States)

^c FHI360 ^*  (United States)

^d BRIGHAM AND WOMEN S HOSPITAL   (United States)

^e UNIVERSITY OF ZIMBABWE   (Zimbabwe)

Author keywords

bacterial vaginosis; incidence; prevalence; vitamin D; Zimbabwe

Indexed keywords

25 HYDROXYVITAMIN D; 25-HYDROXYVITAMIN D; VITAMIN D;

ADULT; ARTICLE; CONFIDENCE INTERVAL; CROSS-SECTIONAL STUDY; FEMALE; FOLLOW UP; GROUPS BY AGE; HUMAN; INCIDENCE; MAJOR CLINICAL STUDY; PREGNANT WOMAN; PREVALENCE; PRIORITY JOURNAL; VAGINITIS; VITAMIN BLOOD LEVEL; VITAMIN D DEFICIENCY; ZIMBABWEAN; ANALOGS AND DERIVATIVES; BLOOD; COMORBIDITY; VAGINOSIS, BACTERIAL; YOUNG ADULT; ZIMBABWE;

ADULT; COMORBIDITY; FEMALE; HUMANS; INCIDENCE; PREVALENCE; VAGINOSIS, BACTERIAL; VITAMIN D; VITAMIN D DEFICIENCY; YOUNG ADULT; ZIMBABWE;

EID: 84963553691     PISSN: 00029378     EISSN: 10976868     Source Type: Journal    
DOI: 10.1016/j.ajog.2016.02.045     Document Type: Article

References (46)

1. 1 Hillier, S., Marrazzo, J.M., Holmes, K.K., Bacterial vaginosis. Holmes, K.K., Sparling, P.F., Mårdh, P., et al. (eds.) Sexually transmitted diseases, 4th ed., 2008, McGraw-Hill, New York.
2. 2 Oleen-Burkey, M.A., Hillier, S.L., Pregnancy complications associated with bacterial vaginosis and their estimated costs. Infect Dis Obstet Gynecol 3 (1995), 149–157.
3. 3 Cohen, C.R., Lingappa, J.R., Baeten, J.M., et al. Bacterial vaginosis associated with increased risk of female-to-male HIV-1 transmission: a prospective cohort analysis among African couples. PLoS Med, 9, 2012, e1001251.
4. 4 Van Oostrum, N., De Sutter, P., Meys, J., et al. Risks associated with bacterial vaginosis in infertility patients: a systematic review and meta-analysis. Hum Reprod 28 (2013), 1809–1815.
5. 5 Buve, A., Jespers, V., Crucitti, T., Fichorova, R.N., The vaginal microbiota and susceptibility to HIV. AIDS 28 (2014), 2333–2344.
6. 6 Bradshaw, C.S., Morton, A.N., Garland, S.M., Morris, M.B., Moss, L.M., Fairley, C.K., Higher-risk behavioral practices associated with bacterial vaginosis compared with vaginal candidiasis. Obstet Gynecol 106 (2005), 105–114.
7. 7 Hawes, S.E., Hillier, S.L., Benedetti, J., et al. Hydrogen peroxide-producing lactobacilli and acquisition of vaginal infections. J Infect Dis 174 (1996), 1058–1063.
8. 8 Evans, A.L., Scally, A.J., Wellard, S.J., Wilson, J.D., Prevalence of bacterial vaginosis in lesbians and heterosexual women in a community setting. Sex Transm Infect 83 (2007), 470–475.
9. 9 Yotebieng, M., Turner, A.N., Hoke, T.H., Van Damme, K., Rasolofomanana, J.R., Behets, F., Effect of consistent condom use on 6-month prevalence of bacterial vaginosis varies by baseline BV status. Trop Med Int Health 14 (2009), 480–486.
10. 10 Esber, A., Vicetti Miguel, R.D., Cherpes, T.L., Klebanoff, M.A., Gallo, M.F., Turner, A.N., Risk of bacterial vaginosis among women with herpes simplex virus type 2 infection: a systematic review and meta-analysis. J Infect Dis 212 (2015), 8–17.
11. 11 van De Wijgert, J.H., Mason, P.R., Gwanzura, L., et al. Intravaginal practices, vaginal flora disturbances, and acquisition of sexually transmitted diseases in Zimbabwean women. J Infect Dis 181 (2000), 587–594.
12. 12 Ness, R.B., Hillier, S.L., Richter, H.E., et al. Douching in relation to bacterial vaginosis, lactobacilli, and facultative bacteria in the vagina. Obstet Gynecol, 100, 2002, 765.
13. 13 Ness, R.B., Hillier, S., Richter, H.E., et al. Can known risk factors explain racial differences in the occurrence of bacterial vaginosis?. J Natl Med Assoc 95 (2003), 201–212.
14. 14 Allsworth, J.E., Peipert, J.F., Prevalence of bacterial vaginosis: 2001–2004 National Health and Nutrition Examination Survey data. Obstet Gynecol 109 (2007), 114–120.
15. 15 Korf, H., Decallonne, B., Mathieu, C., Vitamin D for infections. Curr Opin Endocrinol Diabetes Obes 21 (2014), 431–436.
16. 16 Harris, S.S., Vitamin D and African Americans. J Nutr 136 (2006), 1126–1129.
17. 17 Robinson-Cohen, C., Hoofnagle, A.N., Ix, J.H., et al. Racial differences in the association of serum 25-hydroxyvitamin D concentration with coronary heart disease events. JAMA 310 (2013), 179–188.
18. 18 van Ballegooijen, A.J., Robinson-Cohen, C., Katz, R., et al. Vitamin D metabolites and bone mineral density: The multi-ethnic study of atherosclerosis. Bone 78 (2015), 186–193.
19. 19 Bodnar, L.M., Krohn, M.A., Simhan, H.N., Maternal vitamin D deficiency is associated with bacterial vaginosis in the first trimester of pregnancy. J Nutr 139 (2009), 1157–1161.
20. 20 Hensel, K.J., Randis, T.M., Gelber, S.E., et al. Pregnancy-specific association of vitamin D deficiency and bacterial vaginosis. Am J Obstet Gynecol 204 (2011), 41.e1–41.e9.
21. 21 Davis, L.M., Chang, S.C., Mancini, J., et al. Vitamin D insufficiency is prevalent among pregnant African American adolescents. J Pediatr Adolesc Gynecol 23 (2010), 45–52.
22. 22 Dunlop, A.L., Taylor, R.N., Tangpricha, V., et al. Maternal vitamin D, folate, and polyunsaturated fatty acid status and bacterial vaginosis during pregnancy. Infect Dis Obstet Gynecol, 2011, 2011, 216217.
23. 23 French, A.L., Adeyemi, O.M., Agniel, D.M., et al. The association of HIV status with bacterial vaginosis and vitamin D in the United States. J Womens Health (Larchmt) 20 (2011), 1497–1503.
24. 24 Klebanoff, M.A., Turner, A.N., Bacterial vaginosis and season, a proxy for vitamin D status. Sex Transm Dis 41 (2014), 295–299.
25. 25 Hollis, B.W., Johnson, D., Hulsey, T.C., et al. Vitamin D supplementation during pregnancy: double-blind, randomized clinical trial of safety and effectiveness. J Bone Miner Res 26 (2011), 2341–2357.
26. 26 Wagner, C.L., McNeil, R.B., Johnson, D.D., et al. Health characteristics and outcomes of two randomized vitamin D supplementation trials during pregnancy: a combined analysis. J Steroid Biochem Mol Biol 136 (2013), 313–320.
27. 27 Turner, A.N., Carr Reese, P., Fields, K.S., et al. A blinded, randomized controlled trial of high-dose vitamin D supplementation to reduce recurrence of bacterial vaginosis. Am J Obstet Gynecol 211 (2014), 479.e1–479.e13.
28. 28 Taheri, M., Baheiraei, A., Foroushani, A.R., Nikmanesh, B., Modarres, M., Treatment of vitamin D deficiency is an effective method in the elimination of asymptomatic bacterial vaginosis: a placebo-controlled randomized clinical trial. Indian J Med Res 141 (2015), 799–806.
29. 29 Kenyon, C., Colebunders, R., Crucitti, T., The global epidemiology of bacterial vaginosis: a systematic review. Am J Obstet Gynecol 209 (2013), 505–523.
30. 30 Morrison, C.S., Richardson, B.A., Mmiro, F., et al. Hormonal contraception and the risk of HIV acquisition. AIDS 21 (2007), 85–95.
31. 31 van de Wijgert, J.H., Verwijs, M.C., Turner, A.N., Morrison, C.S., Hormonal contraception decreases bacterial vaginosis but oral contraception may increase candidiasis: implications for HIV transmission. AIDS 27 (2013), 2141–2153.
32. 32 Agborsangaya, C., Toriola, A.T., Grankvist, K., et al. The effects of storage time and sampling season on the stability of serum 25-hydroxy vitamin D and androstenedione. Nutr Cancer 62 (2010), 51–57.
33. 33 Amsel, R., Totten, P.A., Spiegel, C.A., et al. Nonspecific vaginitis. Diagnostic criteria and microbial and epidemiologic associations. Am J Med 74 (1983), 14–22.
34. 34 Nugent, R.P., Krohn, M.A., Hillier, S.L., Reliability of diagnosing bacterial vaginosis is improved by a standardized method of gram stain interpretation. J Clin Microbiol 29 (1991), 297–301.
35. 35 Ross, A.C., Taylor, C.L., Yaktine, A.L., et al. Dietary reference intakes for calcium and vitamin D. 2010, Institute of Medicine, National Academy of Sciences, Washington (DC).
36. 36 McNutt, L.A., Wu, C., Xue, X., Hafner, J.P., Estimating the relative risk in cohort studies and clinical trials of common outcomes. Am J Epidemiol 157 (2003), 940–943.
37. 37 Bautista, C.T., Wurapa, E., Sateren, W.B., Morris, S., Hollingsworth, B., Sanchez, J.L., Bacterial vaginosis: a synthesis of the literature on etiology, prevalence, risk factors, and relationship with chlamydia and gonorrhea infections. Mil Med Res, 3, 2016, 4.
38. 38 Tobian, A.R., Kacker, S., Quinn, T.C., Male circumcision: a globally relevant but under-utilized method for the prevention of HIV and other sexually transmitted infections. Annu Rev Med 65 (2014), 293–306.
39. 39 Cox, D.R., Regression models and life-tables. J R Stat Soc Series B 34 (1972), 187–220.
40. 40 Lewis, R.D., Laing, E.M., Conflicting reports on vitamin D supplementation: evidence from randomized controlled trials. Mol Cell Endocrinol 410 (2015), 11–18.
41. 41 Pérez-López, F.R., Pasupuleti, V., Mezones-Holguin, E., et al. Effect of vitamin D supplementation during pregnancy on maternal and neonatal outcomes: a systematic review and meta-analysis of randomized controlled trials. Fertil Steril 103 (2015), 1278–1288.e4.
42. 42 Wagner, C.L., McNeil, R., Hamilton, S.A., et al. A randomized trial of vitamin D supplementation in 2 community health center networks in South Carolina. Am J Obstet Gynecol 208 (2013), 137.e1–137.e13.
43. 43 Holick, M.F., Binkley, N.C., Bischoff-Ferrari, H.A., et al. Evaluation, treatment, and prevention of vitamin D deficiency: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab 96 (2011), 1911–1930.
44. 44 Rosen, C.J., Abrams, S.A., Aloia, J.F., et al. IOM committee members respond to Endocrine Society vitamin D guideline. J Clin Endocrinol Metab 97 (2012), 1146–1152.
45. 45 Powe, C.E., Evans, M.K., Wenger, J., et al. Vitamin D-binding protein and vitamin D status of black Americans and white Americans. N Engl J Med 369 (2013), 1991–2000.
46. 46 Stoner, K.A., Reighard, S.D., Vicetti Miguel, R.D., et al. Recalcitrance of bacterial vaginosis among herpes-simplex-virus-type-2-seropositive women. J Obstet Gynaecol Res 38 (2012), 77–83.